CNS Pharmaceuticals, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 57.2M |
| FY2023 | 52.7M |
| FY2024 | 445.5K |
| FY2025 | 443.4K |
| FY2026 | 811.4K |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 57.2M |
| FY2023 | 52.7M |
| FY2024 | 445.5K |
| FY2025 | 443.4K |
| FY2026 | 811.4K |